Journal of Leukocyte Biology eBioscience full spectrum cell analysis
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on July 1, 2004

Published online before print April 9, 2004
This Article
Right arrow Full Text (Reprint (PDF))
Right arrow All Versions of this Article:
jlb.0204068v1
76/1/145    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reddy, K. V.
Right arrow Articles by Mackman, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reddy, K. V.
Right arrow Articles by Mackman, N.
© by The Society for Leukocyte Biology
Journal of Leukocyte Biology, doi:10.1189/jlb.0204068


Received for publication February 3, 2004.
Revised March 1, 2004.
Accepted for publication March 9, 2004.


Article

Dexamethasone enhances LPS induction of tissue factor expression in human monocytic cells by increasing tissue factor mRNA stability

K. Veera Reddy *, Gourab Bhattacharjee *, Gernot Schabbauer *, Angela Hollis *, Kevin Kempf *, Michael Tencati *, Maria O’Connell {dagger}, Mausumee Guha {ddagger}, and Nigel Mackman *@

*Departments of Immunology and Cell Biology, The Scripps Research Institute, La Jolla, California; {dagger}MRC Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, United Kingdom; and {ddagger}Isis Pharmaceuticals, Inc., Carlsbad Research Center, California

@ To whom correspondence should be addressed. E-mail: nmackman{at}scripps.edu.


   Abstract

Glucocorticoids, such as dexamethasone (Dex), are used clinically in the treatment of various inflammatory diseases. Dex acts by inhibiting the expression of inflammatory mediators, such as tumor necrosis factor {alpha} (TNF-{alpha}) and monocyte chemoattractant protein-1 (MCP-1). It is surprising that Dex enhances bacterial lipopolysaccharide (LPS) induction of tissue factor (TF) expression in human monocytic cells. TF is a transmembrane glycoprotein that activates the coagulation protease cascade. In this study, we analyze the mechanism by which Dex enhances LPS-induced TF expression in human monocytic cells. We found that Dex reduced LPS-induced TF gene transcription but increased the stability of TF mRNA. Dex decreased the stability of MCP-1 mRNA and did not affect TNF-{alpha} mRNA stability. Finally, we showed that Dex increased the stability of a transcript consisting of the final 297 nucleotides of the TF mRNA in in vitro decay assays. This region contains AU-rich elements that regulate mRNA stability and may mediate the Dex response. Therefore, despite an inhibition of TF gene transcription, Dex enhances TF expression in human monocytic cells by increasing the stability of TF mRNA.

Key Words: gene regulation • coagulation • glucocorticoid




This article has been cited by other articles:


Home page
J. Physiol.Home page
V. Douard, H.-I. Choi, S. Elshenawy, D. Lagunoff, and R. P. Ferraris
Developmental reprogramming of rat GLUT5 requires glucocorticoid receptor translocation to the nucleus
J. Physiol., August 1, 2008; 586(15): 3657 - 3673.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
T. H. Mogensen, R. S. Berg, S. R. Paludan, and L. Ostergaard
Mechanisms of Dexamethasone-Mediated Inhibition of Toll-Like Receptor Signaling Induced by Neisseria meningitidis and Streptococcus pneumoniae
Infect. Immun., January 1, 2008; 76(1): 189 - 197.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. D. de Kruif, L. C. Lemaire, I. A. Giebelen, M. A. D. van Zoelen, J. M. Pater, P. S. van den Pangaart, A. P. Groot, A. F. de Vos, P. J. Elliott, J. C. M. Meijers, et al.
Prednisolone Dose-Dependently Influences Inflammation and Coagulation during Human Endotoxemia
J. Immunol., February 1, 2007; 178(3): 1845 - 1851.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
H. Cai, C. Song, I. Endoh, J. Goyette, W. Jessup, S. B. Freedman, H. P. McNeil, and C. L. Geczy
Serum Amyloid A Induces Monocyte Tissue Factor
J. Immunol., February 1, 2007; 178(3): 1852 - 1860.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. S. BelAiba, T. Djordjevic, S. Bonello, F. Artunc, F. Lang, J. Hess, and A. Gorlach
The Serum- and Glucocorticoid-Inducible Kinase Sgk-1 Is Involved in Pulmonary Vascular Remodeling: Role in Redox-Sensitive Regulation of Tissue Factor by Thrombin
Circ. Res., March 31, 2006; 98(6): 828 - 836.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2004 by the Society for Leukocyte Biology.